Biogaran takes over Swipha’s activities in Nigeria to produce generic drugs for the local market
All the news from Servier Group
Dr Claude Bertrand, General Director of Research and Development at Servier
Servier and Neurochlore join forces to treat autism in children
Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance